This paper is in the following e-collection/theme issue:

Pilot studies (non-ehealth) (65) Diabetes (187)

Published on in Vol 6, No 7 (2022): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35655, first published .
Comparison of the Impact of Insulin Degludec U100 and Insulin Glargine U300 on Glycemic Variability and Oxidative Stress in Insulin-Naive Patients With Type 2 Diabetes Mellitus: Pilot Study for a Randomized Trial

Comparison of the Impact of Insulin Degludec U100 and Insulin Glargine U300 on Glycemic Variability and Oxidative Stress in Insulin-Naive Patients With Type 2 Diabetes Mellitus: Pilot Study for a Randomized Trial

Comparison of the Impact of Insulin Degludec U100 and Insulin Glargine U300 on Glycemic Variability and Oxidative Stress in Insulin-Naive Patients With Type 2 Diabetes Mellitus: Pilot Study for a Randomized Trial

Authors of this article:

Pavle Vrebalov Cindro1 Author Orcid Image ;   Mladen Krnić2, 3 Author Orcid Image ;   Darko Modun4 Author Orcid Image ;   Jonatan Vuković1 Author Orcid Image ;   Tina Tičinović Kurir2, 3 Author Orcid Image ;   Goran Kardum5 Author Orcid Image ;   Doris Rušić4 Author Orcid Image ;   Ana Šešelja Perišin4 Author Orcid Image ;   Josipa Bukić4 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Huertas Cañas J, Gomez Gutierrez M, Ossa A. What is Glycaemic Variability and which Pharmacological Treatment Options are Effective? A Narrative Review. European Endocrinology 2023;19(2):4 View